Cargando…
Fifteen years of heroin-assisted treatment in a Swiss prison—a retrospective cohort study
BACKGROUND: In the context of the current US opioid crisis and the compelling fact that a quarter to a third of all those addicted to heroin pass through its prisons and jails each year, the care of incarcerated opioid-using individuals (OUI) needs to be improved. AIMS: Little has been published on...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7552491/ https://www.ncbi.nlm.nih.gov/pubmed/33046103 http://dx.doi.org/10.1186/s12954-020-00412-0 |
_version_ | 1783593411298721792 |
---|---|
author | Liebrenz, Michael Gamma, Alex Buadze, Anna Schleifer, Roman Baggio, Stéphanie Schwartz, Bruce Schneeberger, Andres Uchtenhagen, Ambros |
author_facet | Liebrenz, Michael Gamma, Alex Buadze, Anna Schleifer, Roman Baggio, Stéphanie Schwartz, Bruce Schneeberger, Andres Uchtenhagen, Ambros |
author_sort | Liebrenz, Michael |
collection | PubMed |
description | BACKGROUND: In the context of the current US opioid crisis and the compelling fact that a quarter to a third of all those addicted to heroin pass through its prisons and jails each year, the care of incarcerated opioid-using individuals (OUI) needs to be improved. AIMS: Little has been published on the effectiveness or outcomes of heroin-assisted treatment (HAT), a treatment option for severely dependent OUI delivered in a prison setting. The aim of this study was therefore to evaluate such treatment since its implementation. The primary objective was to investigate whether heroin-assisted treatment was associated with severe detrimental health outcomes. The secondary objective was to compare the heroin-assisted treatment group with the general prison population in terms of occupational functioning. DESIGN: Retrospective cohort study SETTING: An open prison with 120 places SUBJECTS: Data on 1885 male prisoners with a total of 2239 imprisonment periods between 2000 and 2015 was available. Ninety-seven inmates in heroin-assisted treatment were compared with 1788 inmates from the general prison population (reference group). MEASUREMENTS: Mortality, medical complications (including overdoses), and work performance (days worked, sick days, and monthly wages earned). FINDINGS: Inmates receiving HAT were on average 1 year younger (33.8 vs. 34.9 years), had longer prison stays (7.3 vs. 3.0 months), were more often of Swiss nationality (68.0% vs. 28.9%), and had committed more drug- and property-related offenses (49.5% vs. 23.2% and 63.9% vs. 38.3%, respectively) compared to the reference group. No serious heroin-related medical complication occurred during the 15-year window of observation among inmates with heroin-assisted treatment. Their work performance was comparable to that of the reference group. CONCLUSIONS: This study shows that heroin-assisted treatment can be a valuable treatment option for severely dependent OUI during imprisonment, can be delivered safely by prison health staff over extended periods of time, and allows OUI in treatment to achieve work performance rates comparable to that of the general prison population. |
format | Online Article Text |
id | pubmed-7552491 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-75524912020-10-13 Fifteen years of heroin-assisted treatment in a Swiss prison—a retrospective cohort study Liebrenz, Michael Gamma, Alex Buadze, Anna Schleifer, Roman Baggio, Stéphanie Schwartz, Bruce Schneeberger, Andres Uchtenhagen, Ambros Harm Reduct J Research BACKGROUND: In the context of the current US opioid crisis and the compelling fact that a quarter to a third of all those addicted to heroin pass through its prisons and jails each year, the care of incarcerated opioid-using individuals (OUI) needs to be improved. AIMS: Little has been published on the effectiveness or outcomes of heroin-assisted treatment (HAT), a treatment option for severely dependent OUI delivered in a prison setting. The aim of this study was therefore to evaluate such treatment since its implementation. The primary objective was to investigate whether heroin-assisted treatment was associated with severe detrimental health outcomes. The secondary objective was to compare the heroin-assisted treatment group with the general prison population in terms of occupational functioning. DESIGN: Retrospective cohort study SETTING: An open prison with 120 places SUBJECTS: Data on 1885 male prisoners with a total of 2239 imprisonment periods between 2000 and 2015 was available. Ninety-seven inmates in heroin-assisted treatment were compared with 1788 inmates from the general prison population (reference group). MEASUREMENTS: Mortality, medical complications (including overdoses), and work performance (days worked, sick days, and monthly wages earned). FINDINGS: Inmates receiving HAT were on average 1 year younger (33.8 vs. 34.9 years), had longer prison stays (7.3 vs. 3.0 months), were more often of Swiss nationality (68.0% vs. 28.9%), and had committed more drug- and property-related offenses (49.5% vs. 23.2% and 63.9% vs. 38.3%, respectively) compared to the reference group. No serious heroin-related medical complication occurred during the 15-year window of observation among inmates with heroin-assisted treatment. Their work performance was comparable to that of the reference group. CONCLUSIONS: This study shows that heroin-assisted treatment can be a valuable treatment option for severely dependent OUI during imprisonment, can be delivered safely by prison health staff over extended periods of time, and allows OUI in treatment to achieve work performance rates comparable to that of the general prison population. BioMed Central 2020-10-13 /pmc/articles/PMC7552491/ /pubmed/33046103 http://dx.doi.org/10.1186/s12954-020-00412-0 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Liebrenz, Michael Gamma, Alex Buadze, Anna Schleifer, Roman Baggio, Stéphanie Schwartz, Bruce Schneeberger, Andres Uchtenhagen, Ambros Fifteen years of heroin-assisted treatment in a Swiss prison—a retrospective cohort study |
title | Fifteen years of heroin-assisted treatment in a Swiss prison—a retrospective cohort study |
title_full | Fifteen years of heroin-assisted treatment in a Swiss prison—a retrospective cohort study |
title_fullStr | Fifteen years of heroin-assisted treatment in a Swiss prison—a retrospective cohort study |
title_full_unstemmed | Fifteen years of heroin-assisted treatment in a Swiss prison—a retrospective cohort study |
title_short | Fifteen years of heroin-assisted treatment in a Swiss prison—a retrospective cohort study |
title_sort | fifteen years of heroin-assisted treatment in a swiss prison—a retrospective cohort study |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7552491/ https://www.ncbi.nlm.nih.gov/pubmed/33046103 http://dx.doi.org/10.1186/s12954-020-00412-0 |
work_keys_str_mv | AT liebrenzmichael fifteenyearsofheroinassistedtreatmentinaswissprisonaretrospectivecohortstudy AT gammaalex fifteenyearsofheroinassistedtreatmentinaswissprisonaretrospectivecohortstudy AT buadzeanna fifteenyearsofheroinassistedtreatmentinaswissprisonaretrospectivecohortstudy AT schleiferroman fifteenyearsofheroinassistedtreatmentinaswissprisonaretrospectivecohortstudy AT baggiostephanie fifteenyearsofheroinassistedtreatmentinaswissprisonaretrospectivecohortstudy AT schwartzbruce fifteenyearsofheroinassistedtreatmentinaswissprisonaretrospectivecohortstudy AT schneebergerandres fifteenyearsofheroinassistedtreatmentinaswissprisonaretrospectivecohortstudy AT uchtenhagenambros fifteenyearsofheroinassistedtreatmentinaswissprisonaretrospectivecohortstudy |